VIVOBIOT (VIVOBIOT) Fair Value & Analysis

IN · Market cap ₹519M

V VIVOBIOT VIVOBIOT · BSE

Price₹23.37

Fair Value₹58.07

Upside+148.5%

Quality26/100

Watch VIVOBIOT for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range ₹36.12 – ₹80.01

Fair value as of: Jul 6, 2026

From 6 valuation models · updated today

Share price −4.4% over the past month.

Price vs Fair Value (12 months)

12‑month range ₹21.05 – ₹41.18 · fair‑value band ₹36.12 – ₹80.01 · the ₹23.37 price screens below the ₹58.07 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

VIVOBIOT (VIVOBIOT) currently trades at ₹23.37, while our model-based Fair Value estimate is ₹58.07 — implying the stock looks roughly 148.5% undervalued today. We read business quality at 26/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, VIVOBIOT generated revenue of ₹543M at a net margin of 11.1%. Revenue grew 15.5% year over year. It earns a return on equity of 5.2%. Net debt stands at ₹659M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹36.12 (bear case) to ₹80.01 (bull case); at ₹23.37, the current price sits below that range. The share trades about 46% below its 52-week high and 15% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹543M

Revenue growth (YoY) +15.5%

Net margin 11.1%

Return on equity 5.2%

Free cash flow −₹25.1M FY2026

Operating margin 16.2%

More key figures

EPS (TTM) ₹-0.8200

EPS growth (YoY) +1.8%

Net debt ₹659M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

VIVOBIOT reported revenue of ₹533M in FY2026 versus ₹514M in FY2022, a compound +0.9%/yr. Reported net income was −₹17.1M in FY2026.

Revenue +0.9%/yr

FY22 ₹514M

FY23 ₹522M

FY24 ₹455M

FY25 ₹467M

FY26 ₹533M

Net income

FY22 ₹22.0M

FY23 ₹26.5M

FY24 ₹25.3M

FY25 ₹72.8M

FY26 −₹17.1M

Is VIVOBIOT fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators

DCF Calculator Graham Number Peter Lynch Formula DDM Calculator Fama-French Model Intrinsic Value

📤 Share or link this analysis

𝕏 Post WhatsApp LinkedIn Reddit

🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

VIVOBIOT · Fair Value
₹58.07 +148%Fair Value
Calculator →

<a href="https://www.fairvalue-calculator.com/stock/VIVOBIOT" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:12px;box-sizing:border-box;font-family:system-ui,-apple-system,Segoe UI,Roboto,sans-serif;text-decoration:none;background:#0f1814;color:#eaf2ed;border:1px solid #2a3a30;border-radius:12px;padding:12px 16px;max-width:360px"><span style="line-height:1.35"><span style="font-size:12px;color:#9fb0a8">VIVOBIOT · Fair Value</span><br><b style="font-size:20px">₹58.07</b> <span style="color:#7BB290;font-weight:700;font-size:14px">+148%</span></span><span style="font-size:11px;color:#7BB290;font-weight:700;margin-left:auto;text-align:right;line-height:1.3">Fair&nbsp;Value<br>Calculator&nbsp;→</span></a>

Cite: Fair Value Calculator (2026). "VIVOBIOT Fair Value". https://www.fairvalue-calculator.com/stock/VIVOBIOT

Explore undervalued stocks

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is VIVOBIOT (VIVOBIOT) undervalued?

As of Jul 6, 2026, our model estimates a fair value of ₹58.07 versus a price of ₹23.37 — about +148% (undervalued). Model-based estimate, not financial advice.

What is the fair value of VIVOBIOT?

Our model-based fair value for VIVOBIOT is ₹58.07 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹23.37.

What is the quality score of VIVOBIOT?

VIVOBIOT has a Quality Score of 26/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of VIVOBIOT (VIVOBIOT)?

VIVOBIOT reported trailing-twelve-month revenue of about ₹543M (latest available figure, as of Jul 6, 2026).

What is the net profit margin of VIVOBIOT?

The net profit margin of VIVOBIOT is about 11.1%, meaning it keeps roughly 11.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.